Patents : |  |
| US Patent No. | Title |
| 7264926 | Nucleoside Phosphatase
|
| 7365202 | Polymorphs of an androgen receptor modulator
|
| 7368527 | HADDE71 polypeptides
|
| 7368531 | Human secreted proteins
|
| 7375198 | Modified nucleic acid probes
|
| 7378492 | CD40-related receptor that binds CD40L
|
| 7381800 | Antibodies to HBIMF63 polypeptide
|
| 7396811 | Subcellular targeting of therapeutic proteins
|
| 7399584 | Method of comparing a target nucleic acid and a reference nucleic acid
|
| 7402387 | Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations
|
| 7410977 | Fluorinated 4-azasteroids as androgen receptor modulators
|
| 7359748 | Apparatus for total immersion photography
|
| 7351566 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
|
| 7339049 | Polymorphisms in human mitochondrial DNA
|
| 7267966 | Complexity management and analysis of genomic DNA
|
| 7268153 | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
| 7285631 | Human cDNAs and proteins and uses thereof
|
| 7291461 | Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
|
| 7312229 | 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
| 7320988 | Methods of lowering lipid levels in a mammal
|
| 7329422 | Pharmaceutical compositions
|
| 7329490 | Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
|
| 7329750 | 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
|
| 7332277 | Methods for detection of genetic disorders
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7415358 | Molecular toxicology modeling
|
| 7482359 | Androgen receptor modulators
|
| 7510881 | Method and kit for the quantitative and/or qualitative detection of components in a sample
|
| 7517522 | ADAMTS13 genes and proteins and variants and therapeutic compositions and methods utilizing the same
|
| 7531300 | Method of diagnosing breast cancer
|
| 7557135 | Inhibitors of cytosolic phospholipase A.sub.2
|
| 7560424 | Targeted therapeutic proteins
|
| 7598031 | Method for the detection of gene transcripts in blood and uses thereof
|
| 7598060 | Rapid analysis of variations in a genome
|
| 7608400 | Methods for detecting a cyclophilin B SNP associated with HERDA
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7482357 | 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
|
| 7469185 | Primary rat hepatocyte toxicity modeling
|
| 7459531 | 50 Human secreted proteins
|
| 7422902 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
| 7426441 | Methods for determining renal toxins
|
| 7432252 | Method of promoting cervical and vaginal secretions
|
| 7432277 | Phosphorus-containing macrocycles
|
| 7435724 | Degradation-resistant mononucleoside phosphate compounds
|
| 7442390 | Method for enhancing engraftment of cells using mesenchymal progenitor cells
|
| 7442501 | SQV nucleic acids and polypeptides
|
| 7442506 | Methods for detection of genetic disorders
|
| 7446110 | 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
| 7447594 | Molecular cardiotoxicology modeling
|
| 7612047 | Degradation-resistant mononucleoside phosphate compounds
|
